💥 Very happy to share our latest preprint completing the CRISPRi trilogy of the lab! 📃📃📃
We used CRISPRi to engineer mycobacterial hypomorphs that are conditionally hyper-resistant or hyper-vulnerable to anti-TB drugs such as INH & ETH ✂️💊🏴☠️🧫🦠
Kudos to Eliana, Sofia & Mika for leading the work! 💪👏👌🥳